FZD7 drives in vitro aggressiveness in stem-A subtype of ovarian cancer via regulation of non-canonical wnt/PCP pathway

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Asad, M ^a   Wong, M K ^a   Tan, T Z ^a   Choolani, M ^b   Low, J ^b,c   Mori, S ^d   Virshup, D ^e   Thiery, J P ^a,c,f,g   Huang, R Y J ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c Cancer Science Institute of Singapore   (Singapore)

^d CANCER INSTITUTE   (Japan)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CASEIN KINASE IEPSILON; CELSR3 PROTEIN; DISHEVELLED 2; DISHEVELLED ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1 PROTEIN; F ACTIN; FRIZZLED FAMILY RECEPTOR 7; FRIZZLED PROTEIN; MYOSIN LIGHT CHAIN; PRICKLE4 PROTEIN; PROFILIN; PROFILIN 2 PROTEIN; PROTEIN P120; PROTEIN TYROSINE KINASE 7; PROTOCADHERIN 9 PROTEIN; PROTOCADHERIN ALPHA1 PROTEIN; PROTOCADHERIN BETA17 PROTEIN; PROTOCADHERIN BETA3 PROTEIN; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPROUTY HOMOLOG 1 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; FZD7 PROTEIN, HUMAN;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL ADHESION; CELL CONTACT; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL JUNCTION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; OVARY CANCER; OVERALL SURVIVAL; PHENOTYPE; PLANAR CELL POLARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TERATOCARCINOMA CELL LINE; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; CELL CYCLE; CELL MOTION; DROSOPHILA; GENETICS; METABOLISM; OVARY TUMOR; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; DROSOPHILA; FEMALE; FRIZZLED RECEPTORS; HUMANS; OVARIAN NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84905460010     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.302     Document Type: Article

References (60)

1. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008; 14: 5198-5208.
2. TCGA (Cancer Genome Atlas Research Network). Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
3. Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med 2013; 5: 983-998.
4. Palacios J, Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 1998; 58: 1344-1347.
5. Kildal W, Risberg B, Abeler VM, Kristensen GB, Sudbø J, Nesland JM et al. Beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. Eur J Cancer 2005; 41: 1127-1134.
6. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of betacatenin- independent Wnt signaling. Dev Cell 2003; 5: 367-377.
7. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
8. Reya T, Duncan A, Ailles L, Domen J, Scherer DC, Willert K et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414.
9. Yu Q, Liu L, Duan Y, Wang Y, Xuan X, Zhou L et al. Wnt/beta-catenin signaling regulates neuronal differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2013; 439: 297-302.
10. Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P et al. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS One 2010; 5: e10456.
11. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 2007; 282: 17259-17271.
12. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999; 144: 1235-1244.
13. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004; 265: 23-32.
14. Katoh M. WNT/PCP signaling pathway and human cancer [review]. Oncol Rep. 2005; 14: 1583-1588.
15. Ridley AJ. Rho proteins and cancer. Breast Cancer Res Treat 2004; 84: 13-19.
16. Zhang Z, Rankin SA, Zorn AM. Different thresholds of Wnt-Frizzled 7 signaling coordinate proliferation, morphogenesis and fate of endoderm progenitor cells. Dev Biol 2013; 378: 1-12.
17. Abu-Elmagd M, Garcia-Morales C, Wheeler GN. Frizzled7 mediates canonical Wnt signaling in neural crest induction. Dev Biol 2006; 298: 285-298.
18. Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan Y et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene 2011; 30: 4437-4446.
19. Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H et al. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer 2009; 101: 1374-1381.
20. Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S et al. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol 2005; 43: 854-862.
21. Kaucká M, Plevová K, Pavlová S, Janovská P, Mishra A, Verner J et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res 2013; 73: 1491-1501.
22. Huang RY,Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 2013; 4: e915.
23. Klein T, Jenny A, Djiane A, Mlodzik M. CKIepsilon/discs overgrown promotes both Wnt-Fz/ beta-catenin and Fz/PCP signaling in Drosophila. Curr Biol 2006; 16: 1337-1343.
24. Lee KH, Johmura Y, Yu LR, Park JE, Gao Y, Bang JK et al. Identification of a novel Wnt5a-CK1e-Dvl2-Plk1-mediated primary cilia disassembly pathway. EMBO J 2012; 31: 3104-3117.
25. Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 2009; 8: 2103-2109.
26. Tanaka S, Akiyoshi T, Mori M, Wands JR, Sugimachi K. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci USA 1998; 95: 10164-10169.
27. Kirikoshi H, Sekihara H, Katoh M. Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. Int J Oncol 2001; 19: 111-115.
28. Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E et al. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 2008; 48: 780-791.
29. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A et al. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 2004; 127: 1110-1122.
30. Vincan E, Darcy PK, Smyth MJ, Thompson EW, Thomas RJ, Phillips WA et al. Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation 2005; 73: 142-153.
31. Vincan E, Flanagan DJ, Pouliot N, Brabletz T, Spaderna S. Variable FZD7 expression in colorectal cancers indicates regulation by the tumour microenvironment. Dev Dyn 2010; 239: 311-317.
32. Melchior K, Weiss J, Zaehres H, Kim YM, Lutzko C, Roosta N et al. The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells. Biol Chem 2008; 389: 897-903.
33. Fernandez A, Huggins IJ, Perna L, Brafman D, Lu D, Yao S et al. The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells. Proc Natl Acad Sci USA 2014; 111: 1409-1414.
34. Assou S, Le Carrour T, Tondeur S, Ström S, Gabelle A, Marty S et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007; 25: 961-973.
35. Dormeyer W, van Hoof D, Braam SR, Heck AJ, Mummery CL, Krijgsveld J. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 2008; 7: 2936-2951.
36. Vijayaragavan K, Szabo E, Bossé M, Ramos-Mejia V, Moon RT, Bhatia M. Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 2009; 4: 248-262.
37. Le Grand F, Jones AE, Seale V, Scimè A, Rudnicki MA. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 2009; 4: 535-547.
38. Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P et al. Anti-RhoA and anti- RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 2005; 11: 267-274.
39. Zhang S, Tang Q, Xu F, Xue Y, Zhen Z, Deng Y et al. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Mol Cancer Res 2009; 7: 570-580.
40. Vincan E, Darcy PK, Farrelly CA, Faux MC, Brabletz T, Ramsay RG. Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene 2007; 26: 2340-2352.
41. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999; 147: 1009-1022.
42. Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol 1997; 139: 1047-1059.
43. Guo X, Wang M, Jiang J, Xie C, Peng F, Li X et al. Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells. Mol Cancer Res 2013; 11: 230-239.
44. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66: 10439-10448.
45. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 2006; 103: 5454-5459.
46. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002; 1: 279-288.
47. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271: 20246-20249.
48. Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B et al. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol. 2011; 13: 49-58.
49. Kraft B, Berger C, Wallkamm V, Steinbeisser H, Wedlich D. Wnt-11 and Fz7 reduce cell adhesion in convergent extension by sequestration of PAPC and C-cadherin. J Cell Biol 2012; 198: 695-709.
50. Brieher WM, Yap AS, Gumbiner BM. Lateral dimerization is required for the homophilic binding activity of C-cadherin. J Cell Biol 1996; 135: 487-496.
51. Yap AS, Brieher WM, Pruschy M, Gumbiner BM. Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. Curr Biol 1997; 7: 308-315.
52. Troyanovsky SM. Regulation of cadherin-based epithelial cell adhesion by endocytosis. Front Biosci (Schol Ed) 2009; 1: 61-67.
53. Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS One 2009; 4: e4580.
54. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature 1999; 401: 345-350.
55. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066-1076.
56. Foldynová -Trantírková S, Sekyrová P, Tmejová K, Brumovská E, Bernatík O, Blankenfeldt W et al. Breast cancer-specific mutations in CK1 epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res 2010; 12: R30.
57. Cong F, Schweizer L, Varmus H. Casein kinase Iepsilon modulates the signaling specificities of dishevelled. Mol Cell Biol 2004; 24: 2000-2011.
58. Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA et al. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med 2012; 4: 952-963.
59. Fujii N, You L, Xu Z, Uematsu K, Shan J, He B et al. An antagonist of dishevelled protein- protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res 2007; 67: 573-579.
60. Pode-Shakked N, Harari-Steinberg O, Haberman-Ziv Y, Rom-Gross E, Bahar S, Omer D et al. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target. Oncogene 2011; 30: 1664-1680.